top of page
NLA_SS_VEGAS_2024_design-01.jpg

2024 NLA Scientific Sessions Abstracts

Click on the posters to see an enlarged version, or scan the QR Codes with your phone to have a touch-free experience. 

Atrial Fibrillation Outcome in Patients with Metabolic Syndrome.

Presenting Author: Joseph Amoah, MD
Authors: Brittany Smith, Michael Fatuyi, Francisco Somaza Cano

1717089209928-da7b036c-c4f3-4e53-975b-73f5054c9f20_1.jpg

Poster 222

NLA28a.png

Kiosk 28

Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Deep and Durable TG Reductions in Patients With SHTG, SHASTA-2 Final Results

Presenting Author: Christie Ballantyne, MD
Authors: Gaudet D, Pall D, Watts GF, Nicholls SJ, Rosenson RS, Modesto K, Chang T, Melquist S, Fu R, Muhsin M, San Martin J

Poster 131

NLA14c.png

Kiosk 28

Study Design of a Phase 3 Randomized Controlled Trial Evaluating the Efficacy and Safety of Pegozafermin in Patients with Severe Hypertriglyceridemia

Presenting Author: Teresa Parli, MD
Authors: Deepak L. Bhatt MD MPH, Maciej Banach MD, Harold E. Bays, MD, Kevin C. Maki PhD, Kausik Ray MD, Guilliermo Umpierrez MD, Cynthia L. Hartsfield PhD, Germaine D. Agollah PhD, Hank Mansbach MD, Teresa Parli MD, John J. P. Kastelein MD PhD, Arun J. Sanyal MD.

1717089629092-527a60e1-2264-4777-a68e-4e929a3d7532_1.jpg

Poster 153

NLA28c.png

Kiosk 28

Treatment Patterns Among Early Inclisiran vs Anti–PCSK9 mAbs Users: A Retrospective Analysis of US Claims Databases

Presenting Author: Xiaoli Niu, PhD
Authors: Lyuba Popadic, Xinshuo Ma, Yousfuf Ali, Pam Kumparatana, Yuqin Wei, Sean McElligott

1717124250413-595a005a-ee95-467e-862b-d98e8341f0a4_1.jpg

Poster 158

NLA28c2.png

Kiosk 28

bottom of page